Celltrion Pharm, Inc. logo

Celltrion Pharm, Inc. (068760)

Market Closed
10 Aug, 06:30
KRX SM KRX SM
45,000. 00
+800
+1.81%
2.71T Market Cap
- P/E Ratio
23.06% Div Yield
81,788 Volume
- Eps
44,200
Previous Close
Add Transaction
Day Range
43,500 45,050
Year Range
37,000 78,300
Want to track 068760 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

068760 closed today higher at ₩45,000, an increase of 1.81% from yesterday's close, completing a monthly increase of 8.5645% or ₩3,550. Over the past 12 months, 068760 stock lost -24.3697%.
068760 pays dividends to its shareholders, with the most recent payment made on Apr 01, 2026. The next estimated payment will be in 4 months ago on Apr 01, 2026 for a total of ₩200.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 85.1212%, based on the last three reports.
Celltrion Pharm, Inc. has completed 11 stock splits, with the recent split occurring on Dec 29, 2025.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).

068760 Chart

People also search for

Hyundai Motor Co.
408,000
+3.1606%
Hyundai Motor Co. Ltd.
193,200
+0.2075%
Hyundai Motor Co. Ltd. Preferred
197,500
0%
Hyundai Motor Co., Ltd. Preferred
201,500
+0.4988%
Kia Corporation
135,500
+0.4448%

Celltrion Pharm, Inc. (068760) FAQ

What is the stock price today?

The current price is ₩45,000.00.

On which exchange is it traded?

Celltrion Pharm, Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 068760.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 23.06%.

What is its market cap?

As of today, the market cap is 2.71T.

Has Celltrion Pharm, Inc. ever had a stock split?

Celltrion Pharm, Inc. had 11 splits and the recent split was on Dec 29, 2025.

Celltrion Pharm, Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Yoo Young-Ho CEO
KRX SM Exchange
KR7068760008 ISIN
South Korea Country
- Employees
29 Dec 2025 Last Dividend
27 Dec 2024 Last Split
- IPO Date

Overview

Celltrion Pharm, Inc. is a prominent pharmaceutical company based in Cheongju-si, South Korea, with a robust history dating back to its founding in 1976. This innovative company specializes in the development and sales of biosimilars and over-the-counter (OTC) drugs within the South Korean market. Celltrion Pharm, Inc. plays a crucial role in the healthcare industry by offering a wide range of therapeutic solutions designed to meet diverse medical needs, including hepatotonic, anti-inflammatory, antihistamine, respiratory, circulatory system, digestive and stomachic treatments. Moreover, the company’s portfolio extends to hormone/metabolic disease therapies, antibiotic/antimycotic medications, nutrientia and tonics, as well as products geared towards immunology and oncology. By serving key healthcare institutions such as university hospitals, along with general pharmacies, Celltrion Pharm, Inc. demonstrates its commitment to enhancing public health through the provision of high-quality pharmaceutical products.

Products and Services

Celltrion Pharm, Inc. offers an extensive array of products and services aimed at improving patient care through innovative pharmaceutical solutions:

  • Hepatotonic Drugs: These are formulated to support liver function, aiding in the detoxification processes and overall liver health.
  • Anti-inflammatory Medications: Used to reduce inflammation and relieve pain, making them essential in the treatment of conditions such as arthritis.
  • Antihistamines: Provide relief from allergic reactions and symptoms by blocking histamine activity in the body.
  • Respiratory Apparatus Treatments: Designed to alleviate symptoms associated with respiratory conditions, enhancing breathing and lung function.
  • Circulatory System Medications: Aimed at improving blood flow and heart health, addressing conditions like hypertension.
  • Digestive and Stomachic Solutions: Help in the management of digestive disorders, ensuring proper gut health and function.
  • Hormone/Metabolic Disease Therapies: Cater to patients with hormonal imbalances and metabolic diseases, offering a pathway to manage these complex conditions.
  • Antibiotic/Antimycotic Medications: Effective in fighting bacterial and fungal infections, ensuring the eradication of pathogenic microorganisms.
  • Nutrientia and Tonics: Provide essential nutrients and energy, supporting overall health and vitality.
  • Immunology Drugs: Focus on the modulation of the immune system, playing a significant role in treating autoimmune diseases and allergies.
  • Oncology Treatments: Comprise therapies for cancer treatment, targeting various types of cancers through advanced pharmaceutical technology.
  • Other Drugs: Celltrion Pharm, Inc. continually expands its product line, exploring new therapeutic areas to meet the evolving needs of the healthcare sector.

Contact Information

Address: 82, 2sandan-ro
Phone: 82 4 3717 7000